Skip to main content

Table 2 SEP latency and amplitude

From: Effects of desflurane and sevoflurane on somatosensory-evoked and motor-evoked potential monitoring during neurosurgery: a randomized controlled trial

Monitoring

Limbs

Groups

Baseline

0.3MAC

0.6MAC

0.9MAC

Latency (ms)

Upper limbs

Desflurane

17.35 ± 1.65

18.73 ± 1.721#

20.01 ± 1.732#

21.44 ± 2.033#

Sevoflurane

17.38 ± 1.53

17.51 ± 1.59

18.87 ± 1.632

20.02 ± 1.743

Lower limbs

Desflurane

37.02 ± 2.25

39.24 ± 2.271#

40.72 ± 2.012#

42.35 ± 2.413#

Sevoflurane

36.97 ± 2.39

37.72 ± 2.21

39.19 ± 2.102

40.82 ± 2.013

Amplitude (μV)

Upper limbs

Desflurane

0.88 ± 0.35

0.79 ± 0.311#

0.70 ± 0.332#

0.53 ± 0.343#

Sevoflurane

0.88 ± 0.47

0.85 ± 0.30

0.78 ± 0.342

0.63 ± 0.313

Lower limbs

Desflurane

0.82 ± 0.33

0.72 ± 0.411#

0.59 ± 0.332#

0.50 ± 0.313#

Sevoflurane

0.83 ± 0.31

0.79 ± 0.30

0.67 ± 0.282

0.61 ± 0.253

  1. 1P < 0.05 versus Baseline
  2. 2P < 0.05 versus 0.3MAC
  3. 3P < 0.05 versus 0.6MAC
  4. #P < 0.05 versus Sevoflurane Group